Buscadays Hasta 40% en libros importados  Ver más

menú

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Targeting the DNA Damage Response for Anti-Cancer Therapy (en Inglés)
Formato
Libro Físico
Editorial
Idioma
Inglés
N° páginas
401
Encuadernación
Tapa Blanda
Dimensiones
23.4 x 15.6 x 2.1 cm
Peso
0.58 kg.
ISBN13
9783030093365

Targeting the DNA Damage Response for Anti-Cancer Therapy (en Inglés)

Pollard, John ; Curtin, Nicola (Autor) · Humana · Tapa Blanda

Targeting the DNA Damage Response for Anti-Cancer Therapy (en Inglés) - Pollard, John ; Curtin, Nicola

Libro Nuevo

$ 259.738

$ 432.896

Ahorras: $ 173.159

40% descuento
  • Estado: Nuevo
Origen: Estados Unidos (Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el Martes 23 de Julio y el Jueves 01 de Agosto.
Lo recibirás en cualquier lugar de Argentina entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Targeting the DNA Damage Response for Anti-Cancer Therapy (en Inglés)"

Over the past decade a complex role for DNA damage response (DDR) in tumorigenesis has emerged. A proficient DDR has been shown to be a primary cause for cellular resistance to the very many DNA damaging drugs, and IR, that are widely used as standard-of-care across multiple cancer types. It has also been shown that defects in this network, predominantly within the ATM mediated signaling pathway, are commonly observed in cancers and may be a primary event during tumorigenesis. Such defects may promote a genomically unstable environment, facilitating the persistence of mutations, any of which may provide a growth or survival advantage to the developing tumor. In addition, these somatic defects provide opportunities to exploit a reliance on remaining repair pathways for survival, a process which has been termed synthetic lethality. As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents thatmay have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR. In this book we will review a series of important topics that are of great interest to a broad range of academic, industrial and clinical researchers, including the basic science of the DDR, its role in tumorigenesis and in dictating response to DNA damaging drugs and IR. Additionally, we will focus on the several proteins that have been targeted in attempts to provide drug candidates, each of which appear to have quite distinct profiles and could represent very different opportunities to provide patient benefit.

Opiniones del libro

Ver más opiniones de clientes
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes